皮肤软组织感染耐甲氧西林金黄色葡萄球菌中碳酸氢钠反应表型的表型与基因型相关性
本研究评估了103株美国临床耐甲氧西林金黄色葡萄球菌(MRSA)皮肤软组织感染(SSTI)分离株和22株欧洲临床SSTI分离株中新型碳酸氢钠(NaHCO3)反应表型的频率,并分析了美国分离株中该表型与特定表型及基因型指标的相关性。结果显示,对头孢唑林(CFZ)的NaHCO3反应表型见于78/103株美国分离株和4/22株英国分离株,对苯唑西林的NaHCO3反应表型见于17/103株美国分离株和1/22株英国分离株。NaHCO3反应性与克隆复合体8/spa型t008高度相关,AraC碳酸氢盐反应调节因子似乎与该表型机制相关,但需进一步研究验证。
要点
- 对CFZ的NaHCO3反应表型见于78/103株美国分离株和4/22株英国分离株。
- 对苯唑西林的NaHCO3反应表型见于17/103株美国分离株和1/22株英国分离株。
- NaHCO3反应性与克隆复合体8/spa型t008高度相关,AraC碳酸氢盐反应调节因子可能参与机制。
核心结论
- NaHCO3反应性与克隆复合体8/spa型t008高度相关,该遗传背景在北美常见循环。
- AraC碳酸氢盐反应调节因子似乎与NaHCO3反应性的机制相关,但需进一步研究验证。
研究设计与样本
- 研究纳入103株美国临床MRSA皮肤软组织感染分离株和22株欧洲临床SSTI分离株。
- 采用抗菌药物敏感性试验确定药敏表型,并进行靶向测序、全基因组测序及全基因组序列分析以识别与NaHCO3反应表型相关的基因型。
- 通过基因表达分析和靶向基因缺失评估特定新基因位点在NaHCO3反应表型中的作用。
主要发现
- 对CFZ的NaHCO3反应表型见于78/103株美国分离株和4/22株英国分离株,对苯唑西林的NaHCO3反应表型见于17/103株美国分离株和1/22株英国分离株。
- 在美国分离株中,对CFZ的NaHCO3反应性与以下因素显著相关:对阿莫西林-克拉维酸的敏感性、特定mecA基因型、克隆复合体8型以及spa型t008。
- 全基因组序列分析发现AraC家族调节因子(SAUSA300_RS00540)中的单核苷酸多态性(SNPs)仅见于NaHCO3无反应的SSTI菌株。
- NaHCO3反应菌株(而非无反应菌株)体外暴露于HCO3导致该基因表达上调超过2倍。
- 缺失该基因使NaHCO3反应菌株MRSA 11/11不再对CFZ表现出NaHCO3反应性,该基因被命名为葡萄球菌AraC碳酸氢盐反应调节因子。
局限性
- AraC碳酸氢盐反应调节因子似乎与NaHCO3反应性的机制相关,但需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objective of this study is to assess the frequency of the novel sodium bicarbonate (NaHCO3)-responsive phenotype, wherein clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates are rendered susceptible to standard-of-care β-lactams in the presence of NaHCO3, in a collection of 103 clinical U.S. MRSA skin and soft-tissue infection (SSTI) isolates and 22 clinical European SSTI isolates. This study determined the correlation between specific phenotypic and genotypic metrics and the NaHCO3-responsive phenotype among U.S. SSTI isolates. METHODS: Antimicrobial susceptibility testing was performed to determine susceptibility phenotypes. Targeted and whole-genome sequencing with a genome-wide sequence analysis were conducted to identify specific and novel genotypes of interest that may be associated with the NaHCO3-responsive phenotype. Gene expression analysis and targeted gene deletion were performed to assess the role of a specific novel genetic locus in the NaHCO3-responsive phenotype. RESULTS: The NaHCO3-responsive phenotype was identified in 78/103 U.S. isolates and 4/22 UK isolates to cefazolin (CFZ), and in 17/103 U.S. isolates and 1/22 UK isolates to oxacillin. In U.S. isolates, a significant association was identified between NaHCO3-responsiveness to CFZ and: (a) susceptibility to amoxicillin-clavulanate; (b) a specific mecA genotype; (c) clonal complex type 8; and (d) spa type t008. Genome-wide sequence analysis identified single nucleotide polymorphisms (SNPs) in an AraC family regulator (SAUSA300_RS00540) to be exclusively found in NaHCO3-non-responsive SSTI strains. In vitro HCO3 exposures of NaHCO3-responsive strains, but not -non-responsive strains, caused >2-fold upregulated expression of this gene. Deletion of this gene rendered NaHCO3-responsive strain MRSA 11/11 no longer NaHCO3-responsive to CFZ; we have termed this gene the staphylococcal AraC bicarbonate-response regulator. DISCUSSION: NaHCO3-responsiveness is highly associated with clonal complex type 8/spa type t008, a commonly circulating genetic background in North America. The AraC bicarbonate-response regulator, staphylococcal AraC bicarbonate-response regulator, appears to be associated with the mechanism of NaHCO3-responsiveness, but more work is needed to verify.
引用
- Ersoy SC, Madrigal SL, Chen L, et al. Phenotypic and genotypic correlates of the sodium bicarbonate-responsive phenotype among methicillin-resistant Staphylococcus aureus isolates from skin and soft-tissue infections. Clin Microbiol Infect. 2024. PMID: 39626860. doi:10.1016/j.cmi.2024.11.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。